logo

For the Inventor, By the Inventor

Emeryville, CA, United States of America

Juan Armas

This inventor holds 2 USPTO granted patents and 3 published patent applications. Top assignee: Slingshot Biosciences, Inc.. Active years: 2025-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Juan Armas. Retrieved from https://idiyas.com/inventor/juan-armas

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 50.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:

goldMedal2 out of 25 
 
Slingshot Biosciences, Inc.
 patents

Years Active: 2025-2026

Loading Chart...
2 patents (USPTO):Explore Patents
1. 12669427 - Size-tunable synthetic particles with tunable optical properties and methods for using the same for immune cell activation (2026-06-30),
2. 12196661 - Size-tunable synthetic particles with tunable optical properties and methods for using the same for immune cell activation (2025-01-14),

Title: Top Inventor in Emeryville

Introduction: Chad Tyler Rigetti is a prominent inventor known for his contributions to the field of quantum computing.

Latest Patents: His recent patents focus on advancements in quantum algorithms and hardware.

Career Highlights: Rigetti has made significant strides in the development of quantum processors and has been recognized for his innovative work in the tech industry.

Collaborations: He has collaborated with various research institutions and tech companies to further the field of quantum technology.

Conclusion: Chad Tyler Rigetti continues to be a leading figure in the evolution of quantum computing, pushing the boundaries of what is possible in this exciting field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…